Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127740241 | 12774024 | 1 | I | 20160903 | 20160912 | 20160923 | 20160923 | EXP | IT-CONCORDIA PHARMACEUTICALS INC.-GSH201609-004722 | CONCORDIA | 36.00 | YR | F | Y | 0.00000 | 20160923 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127740241 | 12774024 | 1 | PS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | U | 9768 | TABLET | |||||||||
| 127740241 | 12774024 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | U | 0 | ||||||||||
| 127740241 | 12774024 | 3 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 127740241 | 12774024 | 4 | C | DELTACORTENE | PREDNISONE | 1 | 0 | ||||||||||||
| 127740241 | 12774024 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127740241 | 12774024 | 1 | Systemic lupus erythematosus |
| 127740241 | 12774024 | 2 | Systemic lupus erythematosus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127740241 | 12774024 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127740241 | 12774024 | Leukopenia | |
| 127740241 | 12774024 | White blood cell analysis abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |